FDA green lights 2nd booster of Pfizer, Moderna COVID shots for older Americans
Coronavirus,FDA,Coronavirus Vaccine,Pfizer,Moderna,Science,Public Health,CDC,Omicron Variant
From the Center
AllSides Media Bias Rating: Center
The U.S. Food and Drug Administration on Tuesday authorized a second booster dose for people age 50 and older of the two most commonly used COVID-19 vaccines, citing data showing waning immunity and the risks posed by Omicron variants of the virus.
Reporting by Michael Erman in New Jersey and Manojna Maddipatla in Bangaluru, Additional reporting by Ahmed Aboulenein in Washington; Editing by Bill Berkrot
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
Related Coverage
AllSides Picks
Red Blue Translator
Anti-vaxxer
Headline Roundup
Fewer International Students Enrolled in US Colleges for Second Consecutive Year
November 16th, 2026
Headline Roundup
SCOTUS Denies Trump's Appeal to Cut DEI Funding to University of California
November 16th, 2026
Recommended Reading
When Democrats Have To Decide
Dan Schnur
November 16th, 2026